-
On September 18th, 2024, The US Food and Drug Administration (FDA) released a final guidance document titled: “Conducting Clinical Trials with Decentralized Elements” which is intended to inform sponsors, investigators, and other clinical trial stakeholders about the proper implementation of decentralized clinical trials (DCT).
-
On August 20th, 2024 the US Food and Drug Administration (FDA) issued a warning letter as a result of an FDA Bioresearch Monitoring (BIMO) Program inspection. The inspection observation was that improper dosing instructions were given to a pediatric patient. Per 21 CFR 312.60, the investigator is responsible for ensuring the study is conducted according to the protocol.
-
The internet is the leading source of health information for most consumers, patients, and healthcare providers, which has led to growing concerns that the spread of misinformation on the internet will put the public at risk of using unsafe or ineffective treatments or therapies. To address the issue the US Food and Drug Administration (FDA) has updated the draft guidance “Addressing Misinformation About Medical Devices and Prescription Drugs Questions and Answers - Guidance for Industry” to inform firms about how to voluntarily address misinformation about their medical products.
-
“Q&A with FDA” is the US Food and Drug Administration’s (FDA) podcast that began in 2022 which answers frequently asked questions by interviewing FDA staff members. The most recent episode was released on August 16th, 2024 titled “Real-World Data and Evidence Generation with Dr. Hilary Marston” hosted by Dr. Sara Roach interviewing Dr. Marston, the FDA’s Chief Medical Officer.
-
A new draft guidance for industry was released on August 22, 2024 by the US Food and Drug Administration (FDA) on Predetermined Change Control Plans (PCCP) for Medical Devices. The draft guidance provides an in-depth history of the origins of PCCPs and how the concept of device changes not requiring new 510(k) submissions has already made in an appearance in other FDA guidances.
In an effort to improve the user experience, the National Library of Medicine (NLM) released updates to ClinicalTrials.gov on December 18, 2017. ClinicalTrials.gov is a searchable database of publicly and privately funded clinical trials being conducted globally. The information is provided by Sponsors and Investigators, and a listing does not indicate the clinical trial has been evaluated by the United States Federal Government.
What is an Early Feasibility Study?
FDA Announces Least Burdensome Provisions Draft Guidance to Modernize Medical Device Approval.
Background:
CRF Health has released an electronic Clinical Outcome Assessments (eCOA) best resources list of 2017. eCOA uses connected electronic devices to directly report clinical trial outcomes and is utilized by subjects, caregivers, and Investigators. By encouraging timely data entry, eCOA supports the ALCOA principle.
Date: January 22, 2018
Time: 11:00 am – 12:30 pm EST
Duration: 90 minutes
Sponsored by: Life Science Training Institute
Webinar: Live interactive session and recorded
Sign up here
